Patent details

EP2945628 Title: ANDROGEN RECEPTOR MODULATOR IN COMBINATION WITH ABIRATERONE ACETATE AND PREDNISONE FOR TREATING PROSTATE CANCER

Basic Information

Publication number:
EP2945628
PCT Application Number:
US2014010777
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP147018659
PCT Publication Number:
WO2014113260
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANDROGEN RECEPTOR MODULATOR IN COMBINATION WITH ABIRATERONE ACETATE AND PREDNISONE FOR TREATING PROSTATE CANCER
French Title of Invention:
MODULATEUR DU RÉCEPTEUR DES ANDROGÈNES EN COMBINAISON D'ACETATE D'ABIRATERONE ET DE PREDNISONE POUR LE TRAITEMENT DU CANCER DE LA PROSTATE
German Title of Invention:
ANDROGENREZEPTORMODULATOR IN KOMBINATION MIT ABIRATERONACETAT UND PREDNISON ZUR BEHANDLUNG VON PROSTATKREBS
SPC Number:

Dates

Filing date:
09/01/2014
Grant date:
15/04/2020
EP Publication Date:
25/11/2015
PCT Publication Date:
24/07/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/04/2020
EP B1 Publication Date:
15/04/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/01/2034
Renunciation date:
Revocation date:
21/06/2021
Annulment date:

Owner

From:
08/04/2020
 
 

Name:
Aragon Pharmaceuticals, Inc.
Address:
10990 Wilshire Blvd. Suite 300, Los Angeles, CA 90024, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/04/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SMITH, Nicholas D.
Address:
United States (US)

2

Name:
HERBERT, Mark R.
Address:
United States (US)

3

Name:
HAGER, Jeffrey H.
Address:
United States (US)

4

Name:
MANEVAL, Edna Chow
Address:
United States (US)

5

Name:
CHEN, Isan
Address:
United States (US)

Priority

Priority Number:
201361752842 P
Priority Date:
15/01/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/48; A61K 31/4439; A61K 38/09; A61K 45/06; A61P 5/28; A61P 17/14; A61P 35/00; A61P 35/04; A61K 47/10; A61K 47/34; A61K 47/44;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2021/12
Publication date:
04/11/2021
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
202016
Publication date:
15/04/2020
Description:
Grant (B1)

2

Issue number:
202143
Publication date:
27/10/2021
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/12/2020
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
21/04/2020 Outgoing Correspondence 1
21/04/2020 Power Of Attorney 1